Article: Senetek announces its male impotency drug therapy eliminates all treatment side effects.

SENETEK ANNOUNCES ITS MALE IMPOTENCY DRUG THERAPY

ELIMINATES ALL TREATMENT SIDE EFFECTS

NEW ORLEANS, May 15 /PRNewswire/ -- Dr. Gerlof Homan, president and CEO of Senetek PLC (NASDAQ: SNTKY) said, "We are happy to report a major development concerning the company's male impotency drug therapy."

At a press conference held today in New Orleans, Homan said, "The advanced testing of our drug therapy for male sexual dysfunction has produced excellent results with no side effects." He noted, "These results further confirm our belief that Senetek's combination drug therapy will become the treatment of choice for most cases of male ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!